Craft

EdiGENE

Total Funding

$143.5 M

EdiGENE Summary

Company Summary

Overview
EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation) for the treatment of genetic disorders. The Company’s technology platform normalizes levels of gene expression without cutting the DNA or RNA.
Type
Private
Status
Active
Founded
2015
HQ
Cambridge, MA, US | view all locations
Website
http://edigene.com/
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

1 location detected

  • Cambridge, MA HQ

    United States

    F18, Riverview II, 245 First St

Footer menu